The recent ruling by the Argentina government to allow medicinal marijuana to be grown at home raises some interesting questions. For starters, how would regulation of the drug affect the quality of the product? How would this change benefit see this page the country’s economy? And how would a regulation of marijuana affect the country’s COVID-19 pandemic? The answer to these questions will likely be revealed when the country finally allows medicinal marijuana to be grown in homes.
The government has implemented a national cannabis program called REPROCANN to support the use of medical marijuana. The new law allows patients and researchers to cultivate cannabis in their own homes. Once the government has approved the products, they can be sold at super autoflowering seeds authorized pharmacies. This will allow them to expand the conditions that qualify for the use of cannabis and prioritize scientific cannabis research. This is welcome news for those suffering from epilepsy or other serious medical conditions that require cannabis.
The new law will require businesses to obtain a license to cultivate medical marijuana. The government will fully reinvest tax fees and license fees. The fee for a cultivation license will be based on the size of the business. The Ministry of Health will issue permits for research purposes, depending on the nature of the study. Both the business license and the cultivation license will be valid for six years and can be renewed if needed. Ultimately, the government will issue one license per citizen.
Despite the legalization of cannabis at home in Argentina, it is still illegal to grow it commercially. But the growing demand for the drug in the home will make this legalization of marijuana more likely. In addition, the country’s highly urban population and availability of delivery services should help the cannabis industry in Argentina flourish. The country has a long way to go to achieve legalization.